88 related articles for article (PubMed ID: 7550067)
1. Gene expression and protein distribution of inter-alpha-trypsin inhibitor in three human hepatoma cell lines.
Héron A; Borghi H; Callé A; Bourguignon J; Diarra-Mehrpour M; Martin JP; Sesboüé R
Cell Biol Int; 1995 Jul; 19(7):593-602. PubMed ID: 7550067
[TBL] [Abstract][Full Text] [Related]
2. Light microscopical detection of inter-alpha-trypsin inhibitor and its different mRNAs in cultured hepatoma Hep G2 cells using immunocytochemical and in situ hybridization techniques.
Borghi H; Callé A; Sesboüé R; Bourguignon J; Diarra-Mehrpour M; Martin JP
Histochem J; 1994 Mar; 26(3):252-61. PubMed ID: 7515868
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.
Werbowetski-Ogilvie TE; Agar NY; Waldkircher de Oliveira RM; Faury D; Antel JP; Jabado N; Del Maestro RF
Cancer Res; 2006 Feb; 66(3):1464-72. PubMed ID: 16452202
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
5. Human inter-alpha-trypsin inhibitor. Synthesis and maturation in hepatoma HepG2 cells.
Bourguignon J; Sesboüé R; Diarra-Mehrpour M; Daveau M; Martin JP
Biochem J; 1989 Jul; 261(1):305-8. PubMed ID: 2476114
[TBL] [Abstract][Full Text] [Related]
6. alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.
Kawai HF; Kaneko S; Honda M; Shirota Y; Kobayashi K
Hepatology; 2001 Mar; 33(3):676-91. PubMed ID: 11230749
[TBL] [Abstract][Full Text] [Related]
7. Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
Kawaguchi K; Honda M; Yamashita T; Shirota Y; Kaneko S
Biochem Biophys Res Commun; 2005 Apr; 329(1):370-80. PubMed ID: 15721316
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
9. Comparison of manganese superoxide dismutase precursor induction ability in human hepatoma cells with or without hepatitis B virus DNA insertion.
Hajnická V; Proost P; Kazár J; Fuchsberger N
Acta Virol; 2000 Dec; 44(6):343-7. PubMed ID: 11332277
[TBL] [Abstract][Full Text] [Related]
10. Post-translational processing of the inter-alpha-trypsin inhibitor in the human hepatoma HepG2 cell line.
Héron A; Bourguignon J; Callé A; Borghi H; Sesboüé R; Diarra-Mehrpour M; Martin JP
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):573-80. PubMed ID: 7522438
[TBL] [Abstract][Full Text] [Related]
11. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Wu TT; Hsieh YH; Hsieh YS; Liu JY
J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
[TBL] [Abstract][Full Text] [Related]
12. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
13. [p53 gene expression of human hepatoma cell lines and their sensitivities to parvovirus H-1].
Guo LP; Li GD; Xu H; Huang QS; Lin WM; Ling WH; Huang H; Luo ZY; Su ZZ
Shi Yan Sheng Wu Xue Bao; 1999 Mar; 32(1):23-9. PubMed ID: 12548791
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth and metastatic spreading by overexpression of inter-alpha-trypsin inhibitor family chains.
Paris S; Sesboüé R; Delpech B; Chauzy C; Thiberville L; Martin JP; Frébourg T; Diarra-Mehrpour M
Int J Cancer; 2002 Feb; 97(5):615-20. PubMed ID: 11807786
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines.
Shu HJ; Saito T; Watanabe H; Ito JI; Takeda H; Okano H; Kawata S
Biochem Biophys Res Commun; 2002 Apr; 293(1):150-4. PubMed ID: 12054577
[TBL] [Abstract][Full Text] [Related]
16. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
[TBL] [Abstract][Full Text] [Related]
18. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
[TBL] [Abstract][Full Text] [Related]
20. Resistance to Fas-mediated apoptosis in human hepatoma cells.
Natoli G; Ianni A; Costanzo A; De Petrillo G; Ilari I; Chirillo P; Balsano C; Levrero M
Oncogene; 1995 Sep; 11(6):1157-64. PubMed ID: 7566976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]